Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001213900-19-021426)

Filing Details

Accession Number:
0001213900-19-021426
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-29 20:34:24
Reporting Period:
2019-10-25
Accepted Time:
2019-10-29 20:34:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1733413 Tff Pharmaceuticals Inc. TFFP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555563 F Harlan Weisman 2600 Via Fortuna, Suite 360
Austin TX 78746		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-25 5,000 $5.00 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Acquisiton 2019-10-29 43,794 $0.00 43,794 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
135,806 2029-10-29 No 4 A Direct
Footnotes
  1. The shares of common stock purchased in the Issuer's initial public offering.
  2. 25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.